Pathways - The Metabolon NewsletterBiochemical Markers of Early-Stage Kidney Toxicity DiscoveredPublished Research Describes Use of Global Biochemical Profiling to Identify Markers Metabolon announced the publication of a research paper co-authored by Metabolon and Teva Pharmaceutical Industries Ltd. which demonstrates the use of global biochemical profiling to better understand drug-induced nephrotoxicity. Click here to learn more. Metabolon Announces Grant ProgramAcademic and Government Researchers Selected to Receive Metabolomic Analysis Metabolon announced the launch of the Metabolomics Research Grant program. The program, designed to help promote and expand metabolomics as a tool for academic and government investigators as well as encourage novel, high-quality researchpublications, offers grants to qualified institutions to conduct global biochemical profiling (metabolomics) studies. These studies provide mechanistic insight into a variety of complex biological systems. Click here to learn more. |